Re: ... removed posts????
|
7
|
Resverlogix Corp.
|
Oct 30, 2017 12:07PM
|
Re: BETonMACE Binary Outcome?
|
7
|
Resverlogix Corp.
|
May 19, 2019 02:55PM
|
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
|
7
|
Zenith Epigenetics
|
Feb 29, 2024 11:15PM
|
Re: The jaded group of posters
|
7
|
Resverlogix Corp.
|
Nov 01, 2021 01:52PM
|
Holly Smokes
|
7
|
Resverlogix Corp.
|
Dec 31, 2021 02:19AM
|
Re: 47 Taken out by Gilead for $4.9 billion
|
7
|
Resverlogix Corp.
|
Mar 05, 2020 01:12PM
|
Re: The move in the stock on Friday was disappointing.
|
7
|
Resverlogix Corp.
|
Nov 02, 2019 05:33PM
|
Re: Corona- COVID-19
|
7
|
Resverlogix Corp.
|
Mar 05, 2020 01:46PM
|
Kelsee has big shoes to fill
|
7
|
Resverlogix Corp.
|
May 30, 2019 07:45PM
|
Re: Don isn't playing the dirty Wall/Bay Street game...
|
7
|
Resverlogix Corp.
|
May 31, 2018 01:37AM
|
Re: Posted on other board by jkj from Google alert / Old or new news?
|
7
|
Resverlogix Corp.
|
Apr 18, 2021 04:52PM
|
Re: Pfizer enzalutimide perspective
|
7
|
Zenith Epigenetics
|
May 16, 2017 03:44AM
|
Re: Some fun with numbers....
|
7
|
Resverlogix Corp.
|
May 23, 2019 02:25AM
|
Re: AHA 2020
|
7
|
Resverlogix Corp.
|
Sep 17, 2020 01:32PM
|
Re: Your thoughts please
|
7
|
Resverlogix Corp.
|
Sep 04, 2024 02:28PM
|
Re: A clinical future for RVX-2135 or just a pre-clinical tool
|
7
|
Zenith Epigenetics
|
Aug 13, 2017 06:57PM
|
Re: If BP buys Apabetalone,...
|
7
|
Resverlogix Corp.
|
Nov 05, 2019 06:20PM
|
Re: ORI
|
7
|
Resverlogix Corp.
|
Oct 16, 2020 12:18PM
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
7
|
Resverlogix Corp.
|
Apr 14, 2021 10:18PM
|
Re: If BP buys Apabetalone,...
|
7
|
Resverlogix Corp.
|
Nov 10, 2019 10:17AM
|